Similar companies
Income Statement (USD)
| Q2 '25 | QoQ | |
|---|---|---|
| Revenue | 3.68B | 21.4% |
| Gross Profit | 3.01B | 23.5% |
| Cost of Revenue | 665M | 12.5% |
| Operating expense | 1.92B | 4.8% |
| Net Income | 1.39B | 72.1% |
| EBITDA | 1.66B | 59.3% |
Balance Sheet (USD)
| Q2 '25 | QoQ | |
|---|---|---|
| Total Assets | 38.2B | 1.8% |
| Total Liabilities | 8.28B | 1.5% |
| Total Equity | 29.9B | 1.9% |
| Shares Outstanding | 109M | 2.3% |
Cash Flow (USD)
| Q2 '25 | QoQ | |
|---|---|---|
| Cash from operations | 1.14B | 9.5% |
| Cash from investing | -1.09B | 269% |
| Cash from financing | -1.13B | 3.6% |
EPS
Financial Highlights for Regeneron in Q2 '25
Regeneron reported a revenue of 3.68B, which is a 21.4% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 3.01B, marking a 23.5% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 665M, a 12.5% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 1.92B, showing a 4.8% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 1.39B, showing a 72.1% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 1.66B, showing a 59.3% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Regeneron with growth in revenue, gross profit, and net income. Higher operating expenses might indicate increased investments or potential inefficiencies.
